Intraluminal arterial transit artifact as a predictor of intracranial large artery stenosis on 3D time of flight MR angiography: Expanding the application of arterial spin labeling MRI in ischemic stroke

Abstract

Objectives: The objective of this study was to evaluate the diagnostic value of “intraluminal arterial transit artifact” in the prediction of intracranial large artery stenosis and to determine if this finding is predictive of ischemic stroke in the territory of the involved artery. Material and Methods: The presence of arterial transit artifact (ATA) within the lumen of an intracranial large vessel was noted on three-dimensional time of flight (3D-TOF) magnetic resonance angiography (MRA) (ATA group). The patients with stenosis but with no ATA (no-ATA group), patients with total occlusion (total occlusion group), and patients with no stenosis/occlusion (normal group) were included in the analysis. Results: There were four groups of patients included in the final analysis, the ATA group (n = 22), the no-ATA group (n = 23), the normal group (n = 25), and the total occlusion group (n = 9). Among patients with any demonstrable stenosis (n = 45), the presence of ATA within the stenotic segment was predictive of stenosis of ≥56% (Sensitivity of 100% [85.2–100, 95% CI], specificity of 100% [86.4–100, 95% CI]), with area under curve of 1.0 (0.92–.0, 95% CI). The presence of intra-arterial ATA signal was significantly associated with ischemic stroke as compared with the no-ATA group (86.36% vs. 26.08%, P = 0.0003). Intraluminal ATA was found to be an independent predictor of infarction in the territory of the involved artery. Conclusion: Intraluminal ATA is predictive of stenosis of at least 56% in the involved artery on 3D-TOF MRA. Intraluminal ATA sign may be an independent predictor of infarction in the territory of the involved artery.

Innovative studies in the Journal of Clinical Imaging Science

“…Intraluminal arterial transit artifact signs may be an independent predictor of infarction in the territory of the involved artery. [ 9 ] Among our top ten best articles, the final mention is from the United States of America, where the authors present that post-treatment positron emission tomography–computed tomography has a high negative presented value for patients with p16+ oropharynx cancer treated with definitive proton therapy and should be used to guide patient management. [ 10 ]…”